Business & Economy
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Source: Business News · Published
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Related stories
Children’s Place files for bankruptcy protection, seeks buyer
The Children's Place has filed for chapter 11 bankruptcy protection and is seeking bids from potential new owners by Dec. 9.
Business News ·
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Business News ·

Steiner and state: Comparing two schools of thought
Children who receive a Steiner education show greater academic success in multiple subjects than those at mainstream schools, a new international study has found.
Phys.org - latest science and technology news stories ·

Trump says he wouldn’t mind Jensen Huang being reinstated as Nvidia CEO, as its shares fall again – business live
Rolling coverage of the latest economic and financial news Insurance industry workers: how is climate-related risk managed in your company? Elon Musk joins 165,000 others calling for Nvidia to bring back Jensen Huang in open letter Britain’s main share index isn’t been dragged ba
Business | The Guardian ·
'We slept here': Flight delays linger as airlines recover from ground stop, but schedule improves Monday
Flight disruptions lingered two days after the Federal Aviation Administration grounded departures nationwide for more than four hours.
Business News ·